CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Celcuity Inc. (CELC)

CELC
$3.99BMid Cap

Next catalyst

PDUFAJun 25, 2027in 220 days

Gedatolisib

PIK3CA-mutant, HR-positive, HER2-negative advanced breast cancer after endocrine therapy

Get an email about CELC's next catalysts

Track Celcuity Inc. (CELC) (CELC) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 1 more upcoming event in our data (NDA filing).See the timeline

Catalyst Timeline

2 upcoming, 1 past

NDA Filing

NDA Filing - gedatolisib

Jun 25, 2027

For PIK3CA-mutant, HR-positive, HER2-negative advanced breast cancer after endocrine therapy. The FDA accepted the sNDA for gedatolisib in PIK3CA-mutant, HR-positive, HER2-negative advanced breast cancer after endocrine therapy and set a PDUFA date of June 25, 2027.

Source
PDUFANext

FDA PDUFA Date gedatolisib

Jun 25, 2027Gedatolisib

For PIK3CA-mutant, HR-positive, HER2-negative advanced breast cancer after endocrine therapy. sNDA filing. AI-extracted from news: <![CDATA[FDA Accepts sNDA for Gedatolisib in PIK3CA-Mutant HR+/HER2– Breast Cancer]]>

Source

Upcoming FDA decisions

How CELC's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQServices-Medical LaboratoriesπŸ‡ΊπŸ‡ΈNorth AmericaMINNEAPOLIS

Frequently asked questions

What is in Celcuity Inc. (CELC)'s drug pipeline?β†’

CatalystAlert tracks 6 drug candidates in Celcuity Inc. (CELC)'s (CELC) pipeline across Phase 3, Phase 2. Its lead program is Gedatolisib (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Celcuity Inc. (CELC)'s next FDA catalyst?β†’

Celcuity Inc. (CELC)'s (CELC) next tracked catalyst is a PDUFA date expected Jun 25, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track CELC biotech catalysts?β†’

Add CELC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Celcuity Inc. (CELC)'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply